Imaging Technology

JUNE 15, 2023

For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

AuntMinnie

JULY 8, 2024

Bracco subsidiary Blue Earth Diagnostics has appointed a new CEO. Marco Campione will report to Bracco Imaging CEO Fulvio Renoldi Bracco and will join Blue Earth Diagnostics' board of directors.

Diagnostic 40

Diagnostic Pharmaceutical Healthcare Healthcare 40

AuntMinnie

OCTOBER 18, 2024

Australia-based Telix Pharmaceuticals has filed with the U.S. The updated business model comprises Therapeutics, Precision Medicine (Diagnostics), Lightpoint (MedTech), and Telix Manufacturing Solutions (TMS). Securities and Exchange Commission (SEC) to list its ordinary shares and trade on the Nasdaq under the ticker symbol “TLX.”

Pharmaceutical 98

Pharmaceutical IT Diagnostic Imaging 98

Imaging Technology

JULY 24, 2024

Not for use in diagnostic procedures. “We The company noted it recently released findings from a study conducted with Quest Diagnostics, a leading provider of diagnostic information services, on the impact of its AI-enabled workflows. Concentriq AP is for research use only.

DICOM 115

DICOM Pharmaceutical Diagnostic Disease 115

Imaging Technology

JULY 25, 2024

Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. a subsidiary of BWX Technologies, Inc.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

Diagnostic Imaging

JULY 5, 2023

The prospective multicenter trial, which is slated to begin patient recruitment in late 2023, will reportedly assess the ability of 64Cu SAR-bisPSMA to diagnose prostate cancer within pelvic lymph nodes.

Pharmaceutical 64

Pharmaceutical Diagnose 64

AuntMinnie

JULY 11, 2023

Pharmaceutical industry companies were involved in payments to diagnostic radiolog.

Diagnostic 40

Diagnostic Radiation Oncology Pharmaceutical Medicare 40

Imaging Technology

APRIL 24, 2023

In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs).

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Government 98

Imaging Technology

MAY 25, 2023

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S.,

Clinic 94

Clinic Healthcare Healthcare Imaging 94

AuntMinnie

DECEMBER 18, 2024

Shuttle Pharmaceuticals Holdings has entered a sponsored research agreement with the University of California, San Francisco (UCSF) to develop Shuttle's ligand to the prostate-specific membrane antigen (PSMA) as a theranostic molecule.

Pharmaceutical 52

Pharmaceutical Diagnostic IT 52

MRI Network

MARCH 25, 2024

Big data has become a pillar in modern pharmaceutical practices. Pharmaceutical companies have also leveraged big data in third-party collaborations, resulting in more efficient product deployment and customer experiences. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98

Pharmaceutical 59

Pharmaceutical Quality and Compliance Clinic Diagnostic 59

AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., subject to its regulatory approval. In a recent phase III trial , the radiotracer was shown to be safe and effective for identifying small lesions, which could allow for earlier diagnosis of the disease.

Pharmaceutical 59

Pharmaceutical Disease Diagnostic IT 59

AuntMinnie

OCTOBER 30, 2024

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 last year to 16.3%

Healthcare 52

Healthcare Healthcare Pharmaceutical Ultrasound 52

Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare 105

Healthcare Healthcare Radiation Oncology Radiation 105

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. RadioGenix Systems have generated almost two million doses of Tc-99m for patients’ diagnostic imaging studies to date, with utilization continuing to steadily increase. Our track record of success includes our program to supply U.S.-produced, Additional n.c.a.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

JULY 31, 2024

The company’s Pharmaceutical Diagnostics segment generated $639 million in second-quarter revenues, a 14% increase on an organic basis over last year, GE HealthCare reported. Pharmaceutical Diagnostics segment EBIT was $200 million, up 31% over last year.

Healthcare 52

Healthcare Healthcare Pharmaceutical Ultrasound 52

Imaging Technology

JULY 25, 2023

RTX-1363S has the potential to transform the way we detect and monitor various epithelial-derived cancers." "We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut , Lantheus' Chief Business Officer. "By

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

AuntMinnie

NOVEMBER 20, 2024

Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine. FAP is a pan-cancer marker expressed in the tumor microenvironment of epithelial cancers and on the surface of some specific cancer types, including sarcomas and mesotheliomas.

Nuclear Medicine 52

Nuclear Medicine Pharmaceutical Radiopharmaceuticals Clinic 52

AuntMinnie

OCTOBER 25, 2023

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Diagnostic Clinic 52

Imaging Technology

NOVEMBER 2, 2023

After regional regulatory approvals, GE HealthCare plans to commercialize the models for use both in pharmaceutical drug development and for clinical decision support. These results are a promising development in the journey towards precision care, selecting treatment pathways based on the individual patient’s likely response.

Healthcare 59

Healthcare Healthcare Pharmaceutical Clinic 59

Imaging Technology

JULY 3, 2024

The rise of precision medicine is putting new pressures on diagnostic laboratories to tap into their pathology data, as whole slide images are among the best representations of disease. The same spatial mapping will also enable Nucleai’s applications to serve as companion diagnostics that match patients to the most effective treatment.

Pharmaceutical 59

Pharmaceutical Diagnostic Patient Care Clinic 59

AuntMinnie

MARCH 14, 2024

Clarity Pharmaceuticals has completed its third cohort in the theranostic SECuRE trial evaluating copper-64 (Cu-64) and copper-67 (Cu-67) sarcophagine chelator technology in patients with metastatic castration-resistant prostate cancer.

Pharmaceutical 52

Pharmaceutical Diagnostic Radiation Oncology IT 52

Imaging Technology

JULY 25, 2024

Sarcopenia is an inevitable symptom of aging, and yet there are no pharmaceutical interventions to prevent or address the issue. Muscle atrophy is a leading contributor to falls, fractures, hospitalization, and comorbidities, accounting for more than $40 billion in annual health care costs in the United States alone.

MRI 104

MRI Pharmaceutical Disease Clinic 104

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

NOVEMBER 20, 2023

In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. milla1cf Mon, 11/20/2023 - 12:27 November 20, 2023 — InMed.AI (InMed Prognostics Inc.), a pioneer in AI -driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749)

Pharmaceutical 104

Pharmaceutical Medical Device Disease Healthcare 104

Imaging Technology

JULY 11, 2023

We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut, Lantheus' Chief Business Officer. "By milla1cf Tue, 07/11/2023 - 09:02 July 11, 2023 — Ratio Therapeutics Inc.

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Disease 75

Imaging Technology

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc.,

Interventional Radiology 105

Interventional Radiology Clinic Healthcare Healthcare 105

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. At the time, their cancer center served a significant cancer population in the region and maintained robust and ever-expanding PET diagnostics.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

AuntMinnie

SEPTEMBER 22, 2024

Telix Pharmaceuticals has inked a deal to acquire Florida-based radiopharmacy network RLS Radiopharmacies for up to $250 million, the companies announced. RLS Radiopharmacies is the third-largest radiopharmacy network in the U.S. said Telix Managing Director and Group Chief Executive Officer Christian Behrenbruch, MD, in a news release.

Radiopharmaceuticals 52

Radiopharmaceuticals Pharmaceutical Diagnostic IT 52

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio.

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

JULY 25, 2023

ii More information: www.bracco.com VUEWAY injection is now available to order from Bracco Diagnostics Inc. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. Manufactured for Bracco Diagnostics Inc. NJ: Bracco Diagnostics Inc.;

MRI 98

MRI Magnetic Resonance Imaging Imaging Diagnostic 98

Imaging Technology

OCTOBER 2, 2024

2, Proscia launched Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics. In a production setting, pharmaceutical companies can reduce AI development time from weeks to hours—allowing therapies to reach patients much sooner.

Pharmaceutical 52

Pharmaceutical Patient Care Diagnose Imaging 52

AuntMinnie

APRIL 22, 2024

For CT and MRI procedures where injected contrast media is ordered, ".

Radiology Technologist 105

Radiology Technologist Medicare Basic Life Support Radiologist 105

Imaging Technology

JUNE 15, 2023

Dr. Guy Lloyd , a cardiologist and specialist in diagnostic imaging who participated in the study, highlights the importance of healthcare leaders preparing for the changes of tomorrow, “AI is going to fundamentally change the way people work,” he predicts.

Healthcare 98

Healthcare Healthcare Clinic Pharmaceutical 98

AuntMinnie

DECEMBER 1, 2023

With Caption Guidance, even healthcare providers without specialized training or experience can perform cardiac ultrasound exams and acquire diagnostic-quality cardiac images, according to the vendor.

Healthcare 98

Healthcare Healthcare X-ray Ultrasound 98

MRI Network

JANUARY 8, 2024

According to Today’s Medical Developments , the highest-performing medical devices in terms of sales are: In vitro diagnostic tools Cardiology devices Diagnostic imaging tools Other top-selling device categories include ophthalmic and dental, while the fastest-growing segment is devices related to neurology.

Medical Device 59

Medical Device Medical Pharmaceutical Healthcare 59

Imaging Technology

JANUARY 5, 2024

The new agreement also provides Curadh access to NorthStar’s integrated radiopharmaceutical development and manufacturing organization to support development and commercialization of future radiopharmaceutical diagnostic and therapeutic agents. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52